New law regulating out-of-pocket drug spending saves cancer patients more than $7,000 a year

The Inflation Reduction Act’s limit on Medicare Part D spending leads to significant savings for patients prescribed oral chemotherapy

September 10, 2024 11:00 AM

Author | Nicole Fawcett

rx bottle orange see through person paying in background

Getty Images

As prescription oral chemotherapies have become a common form of cancer treatment, some patients were paying more than $10,000 a year for medications.

A study finds that efforts to cap prescription drug spending are yielding significant out-of-pocket savings for these patients.

The Inflation Reduction Act, enacted in 2022, included establishing a cap on out-of-pocket spending for those enrolled in Medicare Part D prescription drug plans.

Researchers from the University of Michigan’s Institute for Healthcare Policy and Innovation and Rogel Cancer Center used the online Medicare Part D Plan Finder tool to assess how much patients were paying for the most commonly prescribed oral chemotherapies.

They compared data from 2023, when no out-of-pocket cap was in place, to 2024, when the policy first took effect.

For Medicare Part D beneficiaries, annual out-of-pocket costs for oral cancer medications averaged $11,284 in 2023.

In 2024, the average annual cost for the same medications is estimated to be $3,927.

The median cost saving from 2023 to 2024 is estimated to be $7,260, demonstrating the policy’s effect on decreasing costs for patients.

The study is published in JAMA Network Open.

“People with cancer are already vulnerable to financial distress and medical debt. Our analysis suggests that legislative policy can have a big impact on the cost of cancer care. This is especially critical as lawmakers now consider extending an out-of-pocket cap to commercial insurance,” said lead study author Benjamin Pockros, M.D., M.B.A., a urology resident at Michigan Medicine.

In 2025, an out-of-pocket cap will be set at $2,000, which the researchers predict will result in even greater savings for patients.

Additional authors: Chad Ellimoottil, M.D.; Belal Sbei; Megan Caram, M.D.; Kristian Stensland, M.D., M.P.H., M.S.

Funding: University of Michigan Institute for Healthcare Policy and Innovation.

Paper cited: “Changes in Out-of-Pocket Spending for Common Oral Cancer Medications After the Inflation Reduction Act,” JAMA Network Open. DOI: 10.1001/jamanetworkopen.2024.32456

Sign up for Health Lab newsletters today. Get medical tips from top experts and learn about new scientific discoveries every week.

Sign up for the Health Lab Podcast. Add us wherever you listen to your favorite shows.

Featured News & Stories

cup sample with orange top in front of toilet

Health Lab

Urine-based test detects aggressive prostate cancer

Researchers at have validated a previously developed urine test, which can potentially bypass invasive procedures for prostate cancer detection among men who are unlikely to benefit.

white sneaker feet in dark blue and light blue scrubs rushing a hospital bed into medical area

Health Lab

Firearm hospitalizations dropped before the pandemic, then shot up

Hospital stays related to gun injuries dipped then rose sharply, and paralleled gun sales trends, with disparities by age, race and health insurance status.

outline of a child and dna floating around purple shadowing some dark navy

Health Lab

Researchers tackle rare, aggressive tumors in children

ATRT are rare, aggressive tumors. A lot of research has been done in identifying their cause and there are good therapies available. However, more research needs to be done. This is a Q&A article to raise awareness about ATRT and highlight the current research.

paperwork with white and blue and red and says medicare john smith hospital part a medical part b 09-01 09-0

Health Lab

How did health insurance coverage changes affect older adults?

Two University of Michigan studies show how past policy decisions have affected older Americans with modest or low incomes.

woman walking on treadmill picking intensity on a chart that reads from easier to harder

Health Lab

Higher costs limit attendance for life changing cardiac rehab

Despite the success cardiac rehabilitation has shown at reducing heart-related deaths and hospital readmissions, higher out-of-pocket costs may prevent patients from participating in the program, a University of Michigan study suggests.

News Release

Eight U-M researchers win PECASE awards

Three U-M medical researchers, and five others from the U-M faculty, have received one of the nation's top honors for scientists and engineers, as announced by the White House.

Global Footer Secondary Navigation